In the week of September 28, 2026, 18 biotech companies filed a new SEC Form D, reporting $457.76M sold in all. The biggest raise was LISATA THERAPEUTICS, INC., at $351.90M (Basking Ridge, NJ). 14 of them filed a Form D for the first time. That is up from 15 the week before, against a 12-week average of 12.5 (SEC Form D, October 2, 2026).
18 biotech companies filed this week, up from 15 the week before, against a 12-week average of 12.5. The biggest raise was LISATA THERAPEUTICS, INC. at $351.90M, based in Basking Ridge, NJ.
Companies raising per week
Every raise this week
| Based | People named | |||
|---|---|---|---|---|
| LISATA THERAPEUTICS, INC. first filing | $351.90M | 2026-10-02 | Basking Ridge, NJ | David Mazzo, James Nisco +7 |
| GENHEALTH, INC. | $16.50M | 2026-09-29 | Vienna, VA | Ritwik Sahu, Ethan Siegel +2 |
| Altay Therapeutics, Inc. first filing | $15.74M | 2026-10-02 | San Carlos, CA | James Breitmeyer, Ali Ozes +5 |
| Pictura Bio US, Inc. first filing | $15M | 2026-09-28 | Oxford, X0 | Alex Wilson, Nicole Robb +2 |
| Vetmab Biosciences, Inc. | $11.44M | 2026-09-29 | San Diego, CA | Denise Bevers, Richard Chin +3 |
| Xact Bio, Inc. first filing | $10M | 2026-09-28 | Boston, MA | Eric Green, Uciane Scarlett +2 |
| Pictura Bio US, Inc. first filing | $9.13M | 2026-09-28 | Oxford, X0 | Alex Wilson, Nicole Robb +2 |
| GT Biopharma, Inc. | $7.75M | 2026-09-29 | San Francisco, CA | Michael Breen, Alan Urban +3 |
| Evia Bio, Inc. first filing | $5.45M | 2026-09-28 | Minneapolis, MN | Jeffrey Allen, Marc Centrella +3 |
| Solaris Endovascular Inc. first filing | $4.97M | 2026-10-01 | Dallas, TX | Randolph Hubbell, Alexander Moreira +4 |
| CAD Therapeutics, Inc. first filing | $4M | 2026-10-02 | New York, NY | Christopher Teas, Sorina Buri |
| Autology, Inc. first filing | $3.38M | 2026-09-30 | Cincinnati, OH | Jordan Miller |
| Sialia Therapeutics, Inc. first filing | $1.50M | 2026-09-29 | Irvine, CA | Litain Yeh |
| Opus KSD, Inc. | $681K | 2026-10-01 | Pembroke, MA | Charles Rogers, Saud Alturki +4 |
| Vertical Longevity Pharmaceuticals, Inc. first filing | $110K | 2026-09-28 | Irvine, CA | David Scieszka |
| Renovare Therapeutics, Inc. first filing | $100K | 2026-10-02 | Boulder, CO | Elizabeth Scott, Stephanie Bryant +1 |
| Pace Pharmaceuticals, Inc. first filing | $50K | 2026-09-28 | Cupertino, CA | Douglas Yao |
| Conexeu Sciences Inc. | $31K | 2026-09-29 | Reno, NV | David Bogart, Miles Harrison +10 |
| Q-Immune, Inc. first filing | $25K | 2026-09-28 | Seattle, WA | Cameron McCann, Stephen Paucha Smith |
First-time filers
Altay Therapeutics, Inc., Pictura Bio US, Inc., Xact Bio, Inc., Renovare Therapeutics, Inc., Q-Immune, Inc., Sialia Therapeutics, Inc., Solaris Endovascular Inc., CAD Therapeutics, Inc., Pace Pharmaceuticals, Inc., Autology, Inc., Pictura Bio US, Inc., LISATA THERAPEUTICS, INC., Evia Bio, Inc., Vertical Longevity Pharmaceuticals, Inc. filed their first Form D on record this week.
Reach the founders of these 18 Biotech companies with verified contacts, and keep them in one pipeline.
Start free in MentionFoxTurn your raise into a launch page, press kit and share cards, built from your own work.
Get your launch kitOther lists this week
AI and software Manufacturing Health care Business services Retail and restaurants
By sector and metro
Biotech in San Francisco Bay Area Biotech in Boston Biotech in Denver and Boulder Biotech in Seattle Biotech in Los Angeles Biotech in San Diego Biotech in Dallas-Fort Worth Biotech in New York Biotech in Washington, DC Biotech in Northern New Jersey Biotech in Minneapolis-St. Paul
Nearby weeks
Week of 2026-09-21 Week of 2026-10-05
How this list is built
Every company here filed a Form D with the SEC in the week 2026-09-28 to 2026-10-04. A Form D is the notice a company files when it sells shares or other securities without a public offering, so it catches seed rounds, small rounds and rounds that were never announced, alongside the large ones that make the news. Only new offerings by operating companies count: amendments, pooled investment funds, real estate vehicles and special purpose vehicles are left out, so each row is a company raising money for itself.
The amount shown is the total the filing reports as sold so far. Some filings report nothing sold yet; those rows show a dash and add nothing to the totals. "First filing" marks a company whose first Form D on record this is. Each company links to our page for the filing, or to the SEC's own copy, and the list can be copied as CSV for a spreadsheet.
Cite this page
https://mentionfox.com/funding/week/2026-40/biotech